PPARA and type 2 diabetes mellitus: The dual PPARα/γ ligand MK-0767, also known as KRP-297, was found to have potent insulin-sensitizing and antihyperglycemic activities in a preclinical model of obese T2DM, ob/ob mice [100,101].